Currently, REX1 is widely used as a stem cell marker, and Rex1 inhibits signaling via the Janus kinase (JAK)/STAT3 pathway during the differentiation of F9 teratocarcinoma stem cells [12]. Here, ZFP42 is linked to teratocarcinoma.